Search

Start Over Keyword survival analysis

  • Impact of Multi-Agent Systemic Therapy on All-Cause and Disease-Specific Survival for People Living with HIV Who Are Diagnosed with Non-Hodgkin Lymphoma: Population-based Analyses from the State of Georgia

    Impact of Multi-Agent Systemic Therapy on All-Cause and Disease-Specific Survival for People Living with HIV Who Are Diagnosed with Non-Hodgkin Lymphoma: Population-based Analyses from the State of Georgia
    Authors:Joseph Lipscomb, Emory UniversityJeffrey M. Switchenko, Emory UniversityChristopher R. Flowers, MD Anderson Cancer CenterTheresa W. Gillespie, Emory UniversityPascale M. Wortley, Georgia Department of Public HealthA. Rana Bayakly, Georgia Department of Public HealthLyn Almon, Emory UniversityKevin C. Ward, Emory University
    Date:2022
    Publisher:Taylor & Francis
    Publication Version:Author Accepted Manuscript (After Peer Review)
    License:Creative Commons Attribution-NonCommercial 4.0 International

  • Global circumferential and radial strain among patients with immune checkpoint inhibitor myocarditis

    Global circumferential and radial strain among patients with immune checkpoint inhibitor myocarditis
    Authors:Thiago Quinaglia, Massachusetts General HospitalCarlos Gongora, Massachusetts General HospitalMagid Awadalla, Massachusetts General HospitalMalek Z.O. Hassan, Massachusetts General HospitalAmna Zafar, Massachusetts General HospitalZsofia D. Drobni, Massachusetts General HospitalSyed S. Mahmood, Weill Cornell MedicineLili Zhang, Albert Einstein College of MedicineOtavio R. Coelho-Filho, State University of CampinasGiselle A. Suero-Abreu, Rutgers New Jersey Medical SchoolAnant Mandawat, Emory UniversityEduardo Zatarain-Nicolás, Hospital General Universitario Gregorio MarañónMichael Mahmoudi, University of SouthamptonRyan Sullivan, Massachusetts General HospitalSarju Ganatra, Lahey Hospital and Medical CenterLucie M. Heinzerling, University Hospital ErlangenFranck Thuny, Aix-Marseille UniversityStephane Ederhy, Hopitaux Universitaires Est ParisienHannah K. Gilman, Massachusetts General HospitalSupraja Sama, Massachusetts General HospitalSofia Nikolaidou, Massachusetts General HospitalAna González Mansilla, Hospital General Universitario Gregorio MarañónAntonio Calles, Hospital General Universitario Gregorio MarañónMarcella Cabral, McGill UniversityFrancisco Fernández-Avilés, Hospital General Universitario Gregorio MarañónJuan José Gavira, Clínica Universidad de NavarraNahikari Salterain González, Clínica Universidad de NavarraManuel García de Yébenes Castro, Clínica Universidad de NavarraAna Barac, MedStar Heart and Vascular InstituteJonathan Afilalo, McGill UniversityDaniel A. Zlotoff, Massachusetts General HospitalLeyre Zubiri, Massachusetts General HospitalKerry L. Reynolds, Massachusetts General HospitalRichard Devereux, Weill Cornell Medical CenterJudy Hung, Harvard UniversityMichael H. Picard, Harvard UniversityEric H. Yang, University of California, Los AngelesDipti Gupta, Weill Cornell MedicineCaroline Michel, McGill UniversityAlexander R. Lyon, Imperial College LondonCarol L. Chen, Weill Cornell MedicineAnju Nohria, Brigham and Women's HospitalMichael G. Fradley, University of PennsylvaniaPaaladinesh Thavendiranathan, University of TorontoTomas G. Neilan, Massachusetts General Hospital
    Date:2022
    Publisher:Elsevier
    Publication Version:Author Accepted Manuscript (After Peer Review)
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

  • Competing Heterogeneities in Vaccine Effectiveness Estimation

    Competing Heterogeneities in Vaccine Effectiveness Estimation
    Authors:Ariel Nikas, Emory UniversityHasan Ahmed, Emory UniversityVeronika I. Zarnitsyna, Emory University
    Date:2023
    Publisher:MDPI
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • A Need for Prospective Long-Term Data to Characterize Cardiovascular Risk Factors in Sepsis Survivors

    A Need for Prospective Long-Term Data to Characterize Cardiovascular Risk Factors in Sepsis Survivors
    Authors:Sivasubramanium Bhavani, Emory University
    Date:2023
    Publisher:LIPPINCOTT WILLIAMS & WILKINS
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • National Cohort Study of Long-Term Exposure to PM2.5 Components and Mortality in Medicare American Older Adults

    National Cohort Study of Long-Term Exposure to PM2.5 Components and Mortality in Medicare American Older Adults
    Authors:Hua Hao, Emory UniversityYifan Wang, Emory UniversityQiao Zhu, Emory UniversityHaisu Zhang, Emory UniversityAndrew Rosenberg, Emory UniversityJoel Schwartz, Harvard TH Chan Sch Publ HlthHeresh Amini, University of CopenhagenAaron van Donkelaar, Washington University at St. LouisRandall Martin, Washington University at St. LouisPengfei Liu, Georgia Institute of Technology, AtlantaRodney Weber, Georgia Institute of Technology, AtlantaArmistead Russel, Georgia Institute of Technology, AtlantaMaayan Yitshak-sade, Icahn Sch Med Mt SinaiHoward Chang, Emory UniversityLiuhua Shi, Emory University
    Date:2023
    Publisher:AMER CHEMICAL SOC
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival

    Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival
    Authors:Brett N Adey, King's College LondonJohnathan Cooper-Knock, The Sheffield Medical SchoolAhmad Al Khleifat, King's College LondonIsabella Fogh, King's College LondonPhilip van Damme, KU Leuven-University of LeuvenPhilippe Corcia, Université de ToursPhilippe Couratier, CHU de LimogesOrla Hardiman, Trinity College DublinRussell McLaughlin, Trinity College DublinMarc Gotkine, Faculty of MedicineVivian Drory, Tel Aviv Sourasky Medical CenterVincenzo Silani, IRCCS Istituto Auxologico ItalianoNicola Ticozzi, IRCCS Istituto Auxologico ItalianoJan H Veldink, University Medical Center UtrechtLeonard H van den Berg, University Medical Center UtrechtMamede de Carvalho, Instituto de Medicina Molecular João Lobo AntunesSusana Pinto, Instituto de Medicina Molecular João Lobo AntunesJesus S Mora Pardina, Hospital San RafaelMónica Povedano Panades, Hospital Universitari de BellvitgePeter M Andersen, Umeå UniversitetMarkus Weber, Neuromuscular Diseases Unit/ALS ClinicNazli A Başak, Koç ÜniversitesiChristoper E Shaw, King's College LondonPamela J Shaw, The Sheffield Medical SchoolKaren E Morrison, School of Medicine, Dentistry and Biomedical SciencesJohn E Landers, University of Massachusetts Chan Medical SchoolJonathan Glass, Emory UniversityPatrick Vourc h, KU Leuven– University Hospital LeuvenRichard JB Dobson, King's College LondonGerome Breen, King's College LondonAmmar Al-Chalabi, King's College LondonAshley R Jones, King's College LondonAlfredo Iacoangeli, King's College London
    Date:2023
    Publisher:Frontiers
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Methylation of CpG Sites as Biomarkers Predictive of Drug-Specific Patient Survival in Cancer

    Methylation of CpG Sites as Biomarkers Predictive of Drug-Specific Patient Survival in Cancer
    Authors:Bridget Neary, Georgia Institute of TechnologyShuting Lin, Georgia Institute of TechnologyPeng Qiu, Emory University
    Date:2022
    Publisher:SAGE Publications Ltd
    Publication Version:Final Published Version
    License:Creative Commons Attribution-NonCommercial 4.0 International

  • Screening for Predictors of Chronic Ciguatera Poisoning: An Exploratory Analysis among Hospitalized Cases from French Polynesia

    Screening for Predictors of Chronic Ciguatera Poisoning: An Exploratory Analysis among Hospitalized Cases from French Polynesia
    Authors:Clémence Mahana iti Gatti, (IFREMER, ILM, IRD, Univ. Polynésie Française)Kiyojiken Chung, (IFREMER, ILM, IRD, Univ. Polynésie Française)Erwan Oehler, Centre Hospitalier de Polynésie française, PapeeteTJ Pierce, Emory UniversityMatthew Gribble, Emory UniversityMireille Chinain, University of Alabama at Birmingham
    Date:2021
    Publisher:MDPI
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis

    Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
    Authors:Sabrina Paganoni, Harvard Medical SchoolSuzanne Hendrix, Pentara Corporation, Millcreek UtahSamuel P Dickson, Pentara Corporation, Millcreek UtahNewman Knowlton, Pentara Corporation, Millcreek UtahEric A Macklin, Harvard Medical SchoolJames D Berry, Harvard Medical SchoolMicheal A Elliott, Swedish Neuroscience Institute, SeattleSamuel Maiser, Hennepin Healthcare, MinneapolisChafic Karam, Oregon Health & Science University, PortlandJames B Caress, Wake Forest School of MedicineMargaret A Owegi, University of MassachusettsAdam Quick, The Ohio State University College of Medicine, ColumbusJames Wymer, University of Florida College of MedicineStephen A Goutman, University of Michigan, Ann ArborDaragh Heitzman, Texas Neurology, Dallas TexasTerry D Heiman-Patterson, Temple University, PhiladelphiaCarlayne E Jackson, The University of Texas Health Science Center at San AntonioColin Quinn, University of Pennsylvania, PhiladelphiaJeffrey D Rothstein, Johns Hopkins University, BaltimoreEdward J Kasarskis, University of Kentucky, LexingtonJonathan Katz, California Pacific Medical Center Research InstituteLiberty Jenkins, California Pacific Medical Center Research InstituteShafeeq Ladha, Barrow Neurological InstituteTimothy M Miller, Washington University School of Medicine in St. LouisStephen N Scelsa, Icahn School of Medicine at Mount Sinai, New YorkTuan H Vu, University of South Florida MorsaniChristina Fournier, Emory UniversityJonathan Glass, Emory UniversityKristin M Johnson, Ochsner Health System, New OrleansAndrea Swenson, University of Iowa, Iowa CityNamita A Goyal, University of California, IrvineGary L Pattee, Lincoln NebraskaPatricia L Andres, Independent Consultant, Nobleboro MaineSuma Babu, Harvard Medical SchoolMarianne Chase, Harvard Medical SchoolDerek Dagostino, Harvard Medical SchoolMeghan Hall, Barrow Neurological InstituteGale Kittle, Barrow Neurological InstituteMatthew Eydinov, Harvard Medical SchoolMichelle McGovern, Harvard Medical SchoolJoseph Ostrow, Harvard Medical SchoolLindsay Pothier, Harvard Medical SchoolRandall Randall, Barrow Neurological InstituteJeremy M Shefner, Barrow Neurological InstituteAlexender V Sherman, Harvard Medical SchoolMaria E St Pierre, Harvard Medical SchoolEric Tustison, Harvard Medical SchoolPrasha Vigneswaran, Harvard Medical SchoolJason Walker, Harvard Medical SchoolHong Yu, Harvard Medical SchoolJames Chan, Harvard Medical SchoolJanet Wittes, Statistics Collaborative, Inc.Zi-Fan Yu, Statistics Collaborative, Inc.Joshua Cohen, Amylyx Pharmaceuticals, Inc., CambridgeJustin Klee, Amylyx Pharmaceuticals, Inc., CambridgeKent Leslie, Amylyx Pharmaceuticals, Inc., CambridgeRudolph E Tanzi, Harvard Medical SchoolWalter Gilbert, Harvard UniversityPatrick D Yeramian, Amylyx Pharmaceuticals, Inc., CambridgeDavid Schoenfeld, Harvard Medical SchoolMerit E Cudkowicz, Harvard Medical School
    Date:2020
    Publisher:WILEY
    Publication Version:Final Published Version
    License:Creative Commons Attribution-NonCommercial 4.0 International

  • Association of prediagnostic vitamin D status with mortality among colorectal cancer patients differs by common, inherited vitamin D-binding protein isoforms

    Association of prediagnostic vitamin D status with mortality among colorectal cancer patients differs by common, inherited vitamin D-binding protein isoforms
    Authors:David Corley Gibbs, Emory UniversityRoberd Bostick, Emory UniversityMarjorie McCullough, Emory UniversityCaroline Y. Um, American Cancer SocietyW Dana Flanders, Emory UniversityMazda Jenab, International Agency for Research on CancerElisabete Weiderpass, International Agency for Research on CancerBjorn Gylling, Umea UniversityInger T. Gram, University of TromsoAlicia K. Heath, Imperial College LondonSandra Colorado-Yohar, Murcia Regional Health CouncilChristina C. Dahm, Aarhus UniversityBas Bueno-de-Mesquita, National Institute for Public Health and the EnvironmentAurora Perez-Cornago, University of OxfordAntonia Trichopoulou, Hellen Health FoundationRosario Tumino, Provincial Health AuthorityTilman Kuhn, German Cancer Research CenterVeronika Fedirko, Emory University
    Date:2020
    Publisher:WILEY
    Publication Version:Author Accepted Manuscript (After Peer Review)